Literature DB >> 8417048

Percutaneous balloon pericardiotomy for the treatment of cardiac tamponade and large pericardial effusions: description of technique and report of the first 50 cases.

A A Ziskind1, A C Pearce, C C Lemmon, S Burstein, L W Gimple, H C Herrmann, R McKay, P C Block, H Waldman, I F Palacios.   

Abstract

OBJECTIVES: This study describes the technique, clinical characteristics and results of the first 50 patients undergoing percutaneous balloon pericardiotomy as part of a multicenter registry.
BACKGROUND: Percutaneous balloon pericardiotomy involves the use of a percutaneous balloon dilating catheter to create a nonsurgical pericardial window.
METHODS: Patients eligible for percutaneous balloon pericardiotomy had either cardiac tamponade (n = 36) or a moderate to large pericardial effusion (n = 14). In addition to clinical follow-up, serial echocardiograms and chest X-ray films were obtained.
RESULTS: The procedure was considered successful in 46 patients after a mean follow-up period of 3.6 +/- 3.3 months. Two patients required an early operation, one for bleeding from a pericardial vessel and one for persistent pericardial catheter drainage. Two patients required a late operation for recurrent tamponade. Minor complications of the procedure included fever in 6 of the first 37 patients (studied before the prophylactic use of antibiotic agents), thoracentesis or chest tube placement in 8 and a small spontaneously resolving pneumothorax in 2. Despite the short-term success of this procedure, the long-term prognosis of the 44 patients with malignant pericardial disease remained poor (mean survival time 3.3 +/- 3.1 months).
CONCLUSIONS: Percutaneous balloon pericardiotomy is successful in helping to manage large pericardial effusions, particularly in patients with a malignant condition. It may become the preferred treatment to avoid a more invasive procedure for patients with pericardial effusion and a limited life expectancy.

Entities:  

Mesh:

Year:  1993        PMID: 8417048     DOI: 10.1016/0735-1097(93)90710-i

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  16 in total

1.  Pericardial Effusion and Tamponade.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-06

Review 2.  Modern approaches and use of surgical treatment for pericardial disease.

Authors:  Edward P Chen; Joseph I Miller
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

3.  Diagnosis and management of pericardial effusion.

Authors:  Jaume Sagristà-Sauleda; Axel Sarrias Mercé; Jordi Soler-Soler
Journal:  World J Cardiol       Date:  2011-05-26

Review 4.  How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?

Authors:  J G Cleland; S Puri
Journal:  Br Heart J       Date:  1994-09

Review 5.  Pericardial Effusion and Cardiac Tamponade in the New Millennium.

Authors:  Brian D Hoit
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 2.931

6.  Percutaneous treatment in patients presenting with malignant cardiac tamponade.

Authors:  P Y Marcy; P Y Bondiau; P Brunner
Journal:  Eur Radiol       Date:  2005-01-21       Impact factor: 5.315

7.  Neoplastic pericardial disease: Old and current strategies for diagnosis and management.

Authors:  Chiara Lestuzzi
Journal:  World J Cardiol       Date:  2010-09-26

8.  Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.

Authors:  K E Sorensen; D S Celermajer; D J Spiegelhalter; D Georgakopoulos; J Robinson; O Thomas; J E Deanfield
Journal:  Br Heart J       Date:  1995-09

9.  Comparison of surgical pericardial drainage with percutaneous catheter drainage for pericardial effusion.

Authors:  Adam J Saltzman; Yehuda E Paz; A Garvey Rene; Philip Green; Ahmed Hassanin; Michael G Argenziano; Leroy Rabbani; George Dangas
Journal:  J Invasive Cardiol       Date:  2012-11       Impact factor: 2.022

10.  A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811).

Authors:  H Kunitoh; T Tamura; T Shibata; M Imai; Y Nishiwaki; M Nishio; A Yokoyama; K Watanabe; K Noda; N Saijo
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.